Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP873148.RAeha5OI2uRjiTBlCirUQI7t_FdmEsuMR_01X7X7ytpjw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP873148.RAeha5OI2uRjiTBlCirUQI7t_FdmEsuMR_01X7X7ytpjw130_assertion type Assertion NP873148.RAeha5OI2uRjiTBlCirUQI7t_FdmEsuMR_01X7X7ytpjw130_head.
- NP873148.RAeha5OI2uRjiTBlCirUQI7t_FdmEsuMR_01X7X7ytpjw130_assertion description "[The diagnosis of therapy-related myeloid leukemia (t-MDS/t-AML) identifies a group of high-risk patients with multiple and varied poor prognostic features.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873148.RAeha5OI2uRjiTBlCirUQI7t_FdmEsuMR_01X7X7ytpjw130_provenance.
- NP873148.RAeha5OI2uRjiTBlCirUQI7t_FdmEsuMR_01X7X7ytpjw130_assertion evidence source_evidence_literature NP873148.RAeha5OI2uRjiTBlCirUQI7t_FdmEsuMR_01X7X7ytpjw130_provenance.
- NP873148.RAeha5OI2uRjiTBlCirUQI7t_FdmEsuMR_01X7X7ytpjw130_assertion SIO_000772 18024664 NP873148.RAeha5OI2uRjiTBlCirUQI7t_FdmEsuMR_01X7X7ytpjw130_provenance.
- NP873148.RAeha5OI2uRjiTBlCirUQI7t_FdmEsuMR_01X7X7ytpjw130_assertion wasDerivedFrom befree-20150227 NP873148.RAeha5OI2uRjiTBlCirUQI7t_FdmEsuMR_01X7X7ytpjw130_provenance.
- NP873148.RAeha5OI2uRjiTBlCirUQI7t_FdmEsuMR_01X7X7ytpjw130_assertion wasGeneratedBy ECO_0000203 NP873148.RAeha5OI2uRjiTBlCirUQI7t_FdmEsuMR_01X7X7ytpjw130_provenance.